
    
      Patients with a proven history or current exposure will have 4 EDTA tubes drawn,
      approximately 24mL of fresh whole blood for efferocytosis assessment and :

        -  2 x 6mL serum tubes for the assessment of Antinuclear Antibody (ANA) positivity, serum
           high-mobility group box 1 (HMGB1) and osteopontin for patients exposed to asbestos

        -  1 x 6mL serum tube for serum HMGB1 and osteopontin for patients exposed to silica
    
  